FDA grants EUA to Invivyd’s PEMGARDA for COVID-19 pre-exposure prophylaxis in immunocompromised individuals
Invivyd, Inc. (Nasdaq: IVVD), a pioneering biopharmaceutical company dedicated to safeguarding vulnerable populations from severe viral infectious diseases, has recently made headlines with the announcement ... Read More